Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2023 > Vol 4, №9 (2023) > Clinical and anamnestic factors of recurrent endometrial polyps in fertile age

Clinical and anamnestic factors of recurrent endometrial polyps in fertile age

Mekan R. Orazov , Marina B. Khamoshina , Olga F. Poimanova , Irina A. Mullina , Yuliia S. Artemenko

For citation:


  • Abstract
  • About the Author
  • References

Abstract

The prevalence of endometrial polyps (EP) ranges from 7.8 to 34.9%, and in the group of patients with symptoms reaches 24%. The natural course of EP is unclear, the frequency of spontaneous regression of EP varies from 6.3% to 57.1%, but it is impossible to accurately predict the nature of the growth of an individual polyp and the probability of regression. A successful operation does not guarantee against recurrence of the disease: according to various authors, the frequency of postoperative recurrence of EP varies from 5.6% to 43.6%, depending on the duration of observa-tion and the nature of polyps. To improve the results of EP treatment, to determine the target groups for hysteroscopic polypectomy, it is impor-tant to have an understanding of the risk factors for recurrence of EP. The analysis of scientific publications in the databases eLibrary, PubMed, Cochrane Library, Science Direct was performed, according to the keywords endometrial polyps/endometrial polyp, recurrence/recurrence, risk factors/risk factors, reproductive age/reproductive age, premenopausal age/premenopausal age for 2013–2023. The obtained results of the liter-ature analysis allow us to conclude about the influence of age, multiple nature of polyps, chronic endometritis on the risk of recurrence of EP. In addition, other factors may be involved in the development of recurrent polyps. For a more accurate assessment of the contribution of various risk factors to the recurrence of EP, it is necessary to perform high-quality scientific research. The purpose of the work: to analyze the available literature data and summarize the information received to date on the clinical and anamnestic risk factors of EP.
Key words: endometrial polyp, recurrent endometrial polyp, reproductive age, premenopausal age, hysteroscopic polypectomy, risk factors, chronic endometritis.

About the Author

Mekan R. Orazov 1 , Marina B. Khamoshina 1 , Olga F. Poimanova 1 , Irina A. Mullina 1 , Yuliia S. Artemenko 1

1 Patrice Lumumba Peoples' Friendship University of Russia, Moscow, Russia

References

1. Berceanu C, Cernea N, Căpitănescu RG et al. Endometrial polyps. Rom J Morphol Embryol 2022; 63 (2): 323–34.
2. Pereira N, Petrini AC, Lekovich JP et al. Surgical Management of Endometrial Polyps in Infertile Women: A Comprehensive Review. Surg Res Pract 2015; 2015: 914390.
3. Клинические рекомендации «Полипы эндометрия» (одобрено Министерством здравоохранения РФ). Российское общество акушеров-гинекологов. М., 2023; с. 32.
Clinical recommendations “Endometrial polyps” (approved by
the Ministry of Health of the Russian Federation). Russian Society
of Obstetricians and Gynecologists. M., 2023; р. 32 (in
Russian).
4. Yang JH, Chen CD, Chen SU et al. Factors Influencing the Recurrence Potential of Benign Endometrial Polyps after Hysteroscopic Polypectomy. PLoS One 2015; 10 (12): e0144857.
5. Kanthi JM, Remadevi C, Sumathy S et al. Clinical Study of Endometrial Polyp and Role of Diagnostic Hysteroscopy and Blind Avulsion of Polyp. J Clin Diagn Res 2016; 10 (6): QC01-4.
6. Henriquez DDCA, van Dongen H, Wolterbeek R, Jansen FW. Polypectomy in premenopausal women with abnormal uterine bleeding: effectiveness of hysteroscopic removal. J Minim Invasive Gynecol 2007; 14 (1): 59–63.
7. Vitale SG, Haimovich S, Laganà AS et al. Endometrial polyps. An evidence-based diagnosis and management guide. Eur J Obstet Gynecol Reprod Biol 2021; 260: 70–7.
8. Paradisi R, Rossi S, Scifo MC et al. Recurrence of endometrial polyps. Gynecol Obstet Invest 2014; 78 (1): 26–32.
9. Mak KS, Huang YT, Su YY et al. Clinical outcomes in women with endometrial polyps underwent conservative management. Taiwan J Obstet Gynecol 2023; 62 (4): 553–8.
10. Wong M, Crnobrnja B, Liberale V et al. The natural history of endometrial polyps. Hum Reprod 2017; 32 (2): 340–5.
11. Yuksel S, Tuna G, Celik HG, Salman S. Endometrial polyps: Is the prediction of spontaneous regression possible? Obstet Gynecol Sci 2021; 64 (1): 114–21.
12. Okamura A, Yano E, Isono W et al. Predictive factors of spontaneously regressed uterine endometrial polyps during the waiting period before hysteroscopic polypectomy. J Med Case Rep 2021; 15 (1): 384.
13. AlHilli MM, Nixon KE, Hopkins MR et al. Long-term outcomes after intrauterine morcellation vs hysteroscopic resection of endometrial polyps. J Minim Invasive Gynecol 2013; 20: 215–21.
14. Ciscato A, Zare SY, Fadare O. The significance of recurrence in endometrial polyps: a clinicopathologic analysis. Hum Pathol 2020; 100: 38–44.
15. Gu F, Zhang H, Ruan S et al. High number of endometrial polyps is a strong predictor of recurrence: findings of a prospective cohort study in reproductive-age women. Fertil Steril 2018; 109: 493–500.
16. Ceci O, Franchini M, Cardinale S et al. Comparison of endometrial polyp recurrence in fertile women after office hysteroscopic endometrial polypectomy using two widely spread techniques. J Obstet Gynaecol Res 2020; 46 (10): 2084–91.
17. Ciscato A, Zare SY, Fadare O. The significance of recurrence in endometrial polyps: a clinicopathologic analysis. Hum Pathol 2020; 100: 38–44.
18. Wang Y, Yang M, Huang X et al. Prevention of benign endometrial polyp recurrence using a levonorgestrel- releasing intrauterine system in premenopausal patients: a retrospective cohort study. J Minim Invasive Gynecol 2020; 27 (6): 1281–6.
19. Nappi L, Indraccolo U, Di Spiezio Sardo A et al. Are diabetes, hypertension, and obesity independent risk factors for endometrial polyps? J Minim Invasive Gynecol 2009; 16 (2): 157–62.
20. Onalan R, Onalan G, Tonguc E et al. Body mass index is an independent risk factor for the development of endometrial polyps in patients undergoing in vitro fertilization. Fertil Steril 2009; 91 (4): 1056–60.
21. Serhat E, Cogendez E, Selcuk S et al. Is there a relationship between endometrial polyps and obesity, diabetes mellitus, hypertension? Arch Gynecol Obstet 2014; 290 (5): 937–41.
22. Qu D, Liu Y, Zhou H, Wang Z. Chronic endometritis increases the recurrence of endometrial polyps in premenopausal women after hysteroscopic polypectomy. BMC Womens Health 2023; 23 (1): 88.
23. Nijkang NP, Anderson L, Markham R, Manconi F. Endometrial polyps: Pathogenesis, sequelae and treatment. SAGE Open Med 2019; 7: 2050312119848247
24. Carvalho FM, Aguiar FN, Tomioka R et al. Functional endometrial polyps in infertile asymptomatic patients: a possible evolution of vascular changes secondary to endometritis. Eur J Obstet Gynecol Reprod Biol 2013; 170 (1): 152–6.
25. Cicinelli E, Vitagliano A, Loizzi V et al. Altered Gene Expression Encoding Cytochines, Grow Factors and Cell Cycle Regulators in the Endometrium of Women with Chronic Endometritis. Diagnostics (Basel) 2021; 11 (3): 471.
26. De Rijk SR, Steenbergen ME, Nieboer TE, Coppus SF. Atypical Endometrial Polyps and Concurrent Endometrial Cancer: A Systematic Review. Obstet Gynecol 2016; 128 (3): 519–25.
27. Tallini G, Vanni R, Manfioletti G et al. HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes. Lab Invest 2000; 80 (3): 359–69.
28. Bol S, Wanschura S, Thode B et al. An endometrial polyp with a rearrangement of HMGI-C underlying a complex cytogenetic rearrangement involving chromosomes 2 and 12. Cancer Genet Cytogenet 1996; 90 (1): 88–90.
29. Vanni R, Marras S, Andria M, Faa G. Endometrial polyps with predominant stromal component are characterized by a t(6;14)(p21;q24) translocation. Cancer Res 1995; 55 (1): 31–3.
30. Sahoo SS, Aguilar M, Xu Y et al. Endometrial polyps are non-neoplastic but harbor epithelial mutations in endometrial cancer drivers at low allelic frequencies. Mod Pathol 2022; 35 (11): 1702–12.
31. Chapel DB, Howitt BE, Sholl LM et al. Atypical uterine polyps show morphologic and molecular overlap with mullerian adenosarcoma but follow a benign clinical course. Mod Pathol 2022; 35 (1): 106–16.
32. Lu MY, Li XH, Niu JL, Liu B. LIN28B Polymorphisms Confer a Higher Postoperative Recurrence Risk in Reproductive-Age Women with Endometrial Polyps. Dis Markers 2022; 2022: 4824357.

For citation:Orazov M.R., Khamoshina M.B., Poimanova O.F., Mullina I.A., Artemenko Yu.S. Clinical and anamnestic factors of recurrent en-dometrial polyps in fertile age. Clinical review for general practice. 2023; 4 (9): 31–35 (In Russ.). DOI: 10.47407/kr2023.4.9.00305


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru